LMtV Podcast: Let’s ‘meet’ the clinician Dr. Jeannie Kelly examining the risk of COVID-19 during pregnancy and the benefit of vaccination for both pregnant women and their babies in utero and after birth through breast milk.

LMtV Podcast: Let’s ‘meet’ the clinician Dr. Jeannie Kelly examining the risk of COVID-19 during pregnancy and the benefit of vaccination for both pregnant women and their babies in utero and after birth through breast milk.
Clinical research is essential for developing optimal intervention and treatments for COVID-19 patients. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 25 with Jeannie Kelly, MD, MS, an assistant professor of OB-GYN and Medical Director of Maternal-Fetal Transport and Labor and Delivery, about her work examining […]

A Crisis Unfolds: COVID-19 surge gives way to unprecedented collaboration, innovation (Links to an external site)

A Crisis Unfolds: COVID-19 surge gives way to unprecedented collaboration, innovation
The virus had not yet left Wuhan, China, when the School of Medicine, Barnes-Jewish Hospital and BJC HealthCare started bracing for a medical disaster of greater magnitude than any they had ever experienced. Six weeks before COVID-19 reached St. Louis, incident command centers were set up at every BJC hospital, with a joint incident command […]

Findings in the lab of Michael S. Diamond, MD, PhD, show new evidence COVID-19 antibodies, vaccines less effective against variants (Links to an external site)

Findings in the lab of Michael S. Diamond, MD, PhD, show new evidence COVID-19 antibodies, vaccines less effective against variants
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or […]

FDA review confirms safety, efficacy of Johnson & Johnson/Janssen vaccine; under leadership of Rachel Presti, MD, PhD WashU IDCRU was a trial site

FDA review confirms safety, efficacy of Johnson & Johnson/Janssen vaccine; under leadership of Rachel Presti, MD, PhD WashU IDCRU was a trial site
The FDA has confirmed a third vaccine is effective and safe in protecting against COVID-19. The vaccine, manufactured by Johnson & Johnson, is overall 67% effective beginning 14 days after vaccination, 77% effective against severe illness and completely effective against death from COVID-19. Efficacy increased over time and was demonstrated against more infectious variants seen in […]

ID fellow alumnae, Judith A. Aberg, MD, appointed Dean of System Operations for Clinical Sciences at Icahn School of Medicine at Mount Sinai

ID fellow alumnae, Judith A. Aberg, MD, appointed Dean of System Operations for Clinical Sciences at Icahn School of Medicine at Mount Sinai
Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean and President for Academic Affairs at Mount Sinai Health System announced that Judith Aberg, MD, the Dr. George Baehr Professor of Clinical Medicine, has been appointed Dean of System Operations for Clinical Sciences at the Icahn School of Medicine at Mount Sinai. An internationally renowned […]

New Treatment Study for COVID-19 Positive Adults

New Treatment Study for COVID-19 Positive Adults
Washington University School of Medicine announces a new clinical trial for COVID-19 positive patients, STOP COVID Trial. Many patients testing positive for COVID-19 initially experience mild symptoms, but then clinically deteriorate in the second week of illness. The STOP COVID Trial tests a medication (fluvoxamine) for its anti-COVID properties for individuals ages 30 and up […]

LMtV Podcast: Let’s ‘meet’ the virologist, Dr. Sharmila Nair, who is harnessing viruses for cancer therapy

LMtV Podcast: Let’s ‘meet’ the virologist, Dr. Sharmila Nair, who is harnessing viruses for cancer therapy
Use of viruses to target tumors has a long history. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 21 with Sharmila Nair, PhD, an instructor in Infectious Diseases, about her recent work to understand the oncolytic activity of Zika virus for a fatal human cancer, Glioblastoma […]

Mike Diamond, MD, PhD and colleagues lead study that could help improve design of next generation COVID-19 antibody drugs

Mike Diamond, MD, PhD and colleagues lead study that could help improve design of next generation COVID-19 antibody drugs
Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide patients with ready-made antibodies that neutralize the virus, bypassing the body’s slower and sometimes less effective process of making its own antibodies. But such therapies were […]

Liang Shan, PhD, assistant professor of medicine, and colleagues identified a potential way to eradicate the latent HIV infection that lies dormant inside infected immune cells (Links to an external site)

Liang Shan, PhD, assistant professor of medicine, and colleagues identified a potential way to eradicate the latent HIV infection that lies dormant inside infected immune cells
Treatment for HIV has improved tremendously over the past 30 years; once a death sentence, the disease is now a manageable lifelong condition in many parts of the world. Life expectancy is about the same as that of individuals without HIV, though patients must adhere to a strict regimen of daily antiretroviral therapy, or the […]